These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 33412372)

  • 1. Testing the identification effectiveness of an unknown outbreak of the Infectious Diseases Seeker (IDS) using and comparing the novel coronavirus disease (COVID-19) outbreak with the past SARS and MERS epidemics.
    Baldassi F; Cenciarelli O; Malizia A; Gaudio P
    J Infect Public Health; 2021 Jan; 14(1):123-130. PubMed ID: 33412372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious Diseases Seeker (IDS): An Innovative Tool for Prompt Identification of Infectious Diseases during Outbreaks.
    Baldassi F; Carestia M; Moramarco S; Malizia A; Gaudio P
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33804605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
    Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M
    Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Prototype of the Infectious Diseases Seeker (IDS) Software for Prompt Identification of Infectious Diseases.
    Baldassi F; Cenciarelli O; Malizia A; Gaudio P
    J Epidemiol Glob Health; 2020 Dec; 10(4):367-377. PubMed ID: 32959625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: The outbreak caused by a new coronavirus.
    Sifuentes-Rodríguez E; Palacios-Reyes D
    Bol Med Hosp Infant Mex; 2020; 77(2):47-53. PubMed ID: 32226003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal variations in international air travel: implications for modelling the spread of infectious diseases.
    Wardle J; Bhatia S; Cori A; Nouvellet P
    J Travel Med; 2024 Jun; 31(4):. PubMed ID: 38630887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
    Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gordian Knot: Gastrointestinal lesions caused by three highly pathogenic coronaviruses from SARS-CoV and MERS-CoV to SARS-CoV-2.
    Meng X; Lou QY; Yang WY; Chen R; Xu WH; Yang Y; Zhang L; Xu T; Xiang HF
    Eur J Pharmacol; 2021 Jan; 890():173659. PubMed ID: 33131637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Wei M; Yang N; Wang F; Zhao G; Gao H; Li Y
    Disaster Med Public Health Prep; 2020 Dec; 14(6):796-804. PubMed ID: 32418549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors.
    Low ZY; Yip AJW; Sharma A; Lal SK
    Virus Genes; 2021 Aug; 57(4):307-317. PubMed ID: 34061288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive overview of COVID-19 based on current evidence.
    Kang Y; Xu S
    Dermatol Ther; 2020 Sep; 33(5):e13525. PubMed ID: 32378801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak.
    Jee Y
    Epidemiol Health; 2020; 42():e2020013. PubMed ID: 32192278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV).
    Zumla A; Alagaili AN; Cotten M; Azhar EI
    BMC Med; 2016 Sep; 14(1):132. PubMed ID: 27604081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.